Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Denosumab

Amgen’s Xgeva delays prostate cancer bone pain

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared… Amgen’s Xgeva delays prostate cancer bone pain   



perineal laxity3 - anorexia1 - head of the division of urology1 - routine antenatal sonography1 - cystourethrography4 - edema2 - mutation1 - mri6 - chronic autoimmune disease1 - aspirin2 - radium-223 chloride1 - physical activity5 - renal pain1 - monosomy1 - crescenteric glomerulonephritis1 - premenopausal women2 - risks of impotence1 - kreidberg1 - psa velocity screening1 - metanephric blastema1 - bulbocavernosus reflex1 - american society of nephrology22 - hyperpnea1 - obese patients1 - prostate cancer etiology1 - kidney transplantation9 - diagnosis of prostate cancer1 - harvard medical school2 - uterine fibroid embolization1 - avodart1 -